Trial · NCT03197376
Registered outcomes27
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
21 to 27 of 27
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Secondary | Number and Percentage of Subjects With EPI Vaccine Immune Responses (Measles, Rubella and Yellow Fever) | 4 weeks post booster vaccination | Anti-measles IgG, anti-rubella IgG and anti-yellow fever neutralizing antibody titer |
| Other | Proportions and Treatment Group Difference in Proportions of IgG Responders 1 Year Post Booster | One Year Post Booster Vaccination | Treatment group proportions and treatment-group difference in proportions of IgG responders (IgG concentration ≥ 0.35 μg/mL) |
| Other | Serotype-specific Geometric Mean Concentration of IgG Antibody Response and Treatment-Group GMC Ratios One Year Post Booster | One year post booster vaccination | Comparison of Serotype-specific immune persistence responses (antibody concentrations) to PNEUMOSIL in comparison to Synflorix one year post booster |
| Other | Comparison of Serotype-specific Geometric Mean Concentration of IgG Antibody Response 4 Weeks After a Booster Dose to One Year After a Booster Dose | One year post booster vaccination | Comparison of Serotype-specific responses (antibody concentrations) measured by ELISA from 4 weeks after a booster dose to one year after a booster dose |
| Other | Treatment Group Proportions and Treatment-group Difference in Proportions of Functional Antibody Responders (OPA) One Year Post Booster | One year post booster vaccination | Serotype-specific functional antibody titer measured by OPA |
| Other | Serotype-specific OPA Geometric Mean Titer One Year Post Booster | One year post booster vaccination | Serotype-specific functional antibody titer measured by OPA and expressed as OPA GMT in a subset one year post booster |
| Other | Comparison of Functional Response (OPA) From 4 Weeks After a Booster Dose to One Year Post Booster Dose | One year post booster vaccination | Comparison of Serotype-specific booster responses (functional response-OPA) from 4 weeks after a booster dose to one year post booster |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03197376/registered?page=2